| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.1 |